Home

Robert J. Spiegel

CIK 1492256 · Chief Medical Officer · last filed 2026-07-01

Robert J. Spiegel is a Chief Medical Officer who has filed 116 SEC Form 4 insider transactions across 10 companies since 2010. The most recent filing shows the insider was granted $7.8K of GERN on Jul 1, 2026. Across all open-market trades the lifetime net is −$725.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $729.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$729.4K

Companies

10

Total Filings

116

Lifetime Open-Market Net

-$725.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GERN Director 205,810 $1.48 $304.6K -$719.2K 68 2026-07-01
RNXT Director 40,983 $1.16 $47.5K $0 5 2025-10-02
Bio Green Med Solution, Inc. (CYCCP) Delisted Director 39,415 $5.05 $199.0K $0 6 2023-07-03
Athenex, Inc. (ATNX) Delisted Director 4,592 $0.20 $933 $0 9 2023-04-24
Old Ayala, Inc (AYLA) Delisted Director — $0.50 — $0 2 2022-06-15
PDSB Director 48,661 $0.73 $35.6K $0 1 2019-03-18
EDGE Director 1,933 $51.69 $99.9K $33.0K 5 2018-08-15
Sucampo Pharmaceuticals, Inc. (SCMP) Delisted Director 0 — — $0 5 2018-02-13
PTCT Chief Medical Officer 3,239 $74.63 $241.7K -$39.7K 5 2016-01-06
CAPS Director 10 $0.29 $3 $0 3 2012-01-03

Recent Filings

116 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 GERN Grant (A) +6,103 $7.8K EDGAR
2026-05-26 GERN Grant (A) — $0 EDGAR
2026-04-01 GERN Grant (A) +5,243 $7.8K EDGAR
2026-01-05 GERN Grant (A) +5,918 $7.8K EDGAR
2025-10-02 RNXT Grant (A) — $0 EDGAR
2025-10-01 GERN Grant (A) +5,702 $7.8K EDGAR
2025-07-01 GERN Grant (A) +5,540 $7.8K EDGAR
2025-05-22 GERN Grant (A) — $0 EDGAR
2025-04-02 GERN Grant (A) +2,206 $7.8K EDGAR
2025-04-02 GERN Grant (A) +4,378 $16.2K EDGAR
Showing 1–10 of 116
Page 1 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.